|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
2
|
Hakenberg OW: Epidemiologie, diagnose und
urinbasierte untersuchungsverfahren beim harnblasenkarzinom.
Onkologe. 13:1067–1079. 2007.(In German).
|
|
3
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Han Y, Chen J, Zhao X, et al: MicroRNA
expression signatures of bladder cancer revealed by deep
sequencing. PLoS One. 6:e182862011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yoshino H, Chiyomaru T, Enokida H, et al:
The tumour-suppressive function of miR-1 and miR-133a targeting
TAGLN2 in bladder cancer. Br J Cancer. 104:808–818. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Song T, Xia W, Shao N, et al: Differential
miRNA expression profiles in bladder urothelial carcinomas. Asian
Pac J Cancer Prev. 11:905–911. 2010.PubMed/NCBI
|
|
8
|
Wang G, Zhang H, He H, et al:
Up-regulation of microRNA in bladder tumor tissue is not common.
Int Urol Nephrol. 42:95–102. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dyrskjøt L, Ostenfeld MS, Bramsen JB, et
al: Genomic profiling of microRNAs in bladder cancer: miR-129 is
associated with poor outcome and promotes cell death in vitro.
Cancer Res. 69:4851–4860. 2009.PubMed/NCBI
|
|
10
|
Ichimi T, Enokida H, Okuno Y, et al:
Identification of novel microRNA targets based on microRNA
signatures in bladder cancer. Int J Cancer. 125:345–352. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gottardo F, Liu CG, Ferracin M, et al:
Micro-RNA profiling in kidney and bladder cancers. Urol Oncol.
25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miah S, Dudziec E, Drayton RM, et al: An
evaluation of urinary microRNA reveals a high sensitivity for
bladder cancer. Br J Cancer. 107:123–128. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang G, Kwan BC, Lai FM, Chow KM, Li PK
and Szeto CC: Elevated levels of miR-146a and miR-155 in kidney
biopsy and urine from patients with IgA nephropathy. Dis Markers.
30:171–179. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lorenzen JM, Volkmann I, Fiedler J, et al:
Urinary miR-210 as a mediator of acute T-cell mediated rejection in
renal allograft recipients. Am J Transplant. 11:2221–2227. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamada Y, Enokida H, Kojima S, et al:
MiR-96 and miR-183 detection in urine serve as potential tumor
markers of urothelial carcinoma: correlation with stage and grade,
and comparison with urinary cytology. Cancer Sci. 102:522–529.
2011. View Article : Google Scholar
|
|
16
|
Hanke M, Hoefig K, Merz H, et al: A robust
methodology to study urine microRNA as tumor marker: microRNA-126
and microRNA-182 are related to urinary bladder cancer. Urol Oncol.
28:655–661. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheong A, Fountain SJ and Beech DJ:
Quantitative RT-PCR methods for investigation of low copy potassium
channel gene expression in native murine arteries. Methods Mol
Biol. 491:19–33. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jung M, Mollenkopf HJ, Grimm C, et al:
MicroRNA profiling of clear cell renal cell cancer identifies a
robust signature to define renal malignancy. J Cell Mol Med.
13:3918–3928. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Neely LA, Rieger-Christ KM, Neto BS, et
al: A microRNA expression ratio defining the invasive phenotype in
bladder tumors. Urol Oncol. 28:39–48. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Catto JW, Miah S, Owen HC, et al: Distinct
microRNA alterations characterize high- and low-grade bladder
cancer. Cancer Res. 69:8472–8481. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao W, Shen H, Liu L, Xu J, Xu J and Shu
Y: MiR-21 overexpression in human primary squamous cell lung
carcinoma is associated with poor patient prognosis. J Cancer Res
Clin Oncol. 137:557–566. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miko E, Czimmerer Z, Csánky E, Boros G,
Buslig J, Dezso B and Scholtz B: Differentially expressed microRNAs
in small cell lung cancer. Exp Lung Res. 35:646–664. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang W, Peng B, Wang D, Ma X, Jiang D,
Zhao J and Yu L: Human tumor microRNA signatures derived from
large-scale oligonucleotide microarray datasets. Int J Cancer.
129:1624–1634. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kossenkov AV, Vachani A, Chang C, et al:
Resection of non-small cell lung cancers reverses tumor-induced
gene expression changes in the peripheral immune system. Clin
Cancer Res. 17:5867–5877. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Keller A, Leidinger P, Borries A, et al:
miRNAs in lung cancer - studying complex fingerprints in patient’s
blood cells by microarray experiments. BMC Cancer.
9:3532009.PubMed/NCBI
|
|
26
|
Puerta-Gil P, García-Baquero R, Jia AY, et
al: miR-143, miR-222, and miR-452 are useful as tumor
stratification and noninvasive diagnostic biomarkers for bladder
cancer. Am J Pathol. 180:1808–1815. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Snowdon J, Boag S, Feilotter H, Izard J
and Siemens DR: A pilot study of urinary microRNA as a biomarker
for urothelial cancer. Can Urol Assoc J. 1–5. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang G, Chan ES, Kwan BC, Li PK, Yip SK,
Szeto CC and Ng CF: Expression of microRNAs in the urine of
patients with bladder cancer. Clin Genitourin Cancer. 10:106–113.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Abdalla MA and Haj-Ahmad Y: Promising
candidate urinary microRNA biomarkers for the early detection of
hepatocellular carcinoma among high-risk Hepatitis C virus Egyptian
patients. J Cancer. 3:19–31. 2012. View
Article : Google Scholar
|
|
30
|
Hidaka H, Seki N, Yoshino H, et al: Tumor
suppressive microRNA-1285 regulates novel molecular targets:
Aberrant expression and functional significance in renal cell
carcinoma. Oncotarget. 3:44–57. 2012.PubMed/NCBI
|
|
31
|
Zhang S, Shan C, Kong G, Du Y, Ye L and
Zhang X: MicroRNA-520e suppresses growth of hepatoma cells by
targeting the NF-κB-inducing kinase (NIK). Oncogene. 31:3607–3620.
2012.PubMed/NCBI
|
|
32
|
Bustin SA: Quantification of mRNA using
real-time reverse transcription PCR (RT-PCR): trends and problems.
J Mol Endocrinol. 29:23–39. 2002. View Article : Google Scholar : PubMed/NCBI
|
